Anamorelin 10mg 10mg | Purity Not Available
Adooq Bioscience
Anamorelin is currently under development for the management of non-small lung cancer associated cachexia/anorexia.
More Information Supplier PageAnamorelin is currently under development for the management of non-small lung cancer associated cachexia/anorexia.
More Information Supplier PageAnamorelin is currently under development for the management of non-small lung cancer associated cachexia/anorexia.
More Information Supplier PageAnamorelin is currently under development for the management of non-small lung cancer associated cachexia/anorexia.
More Information Supplier PageAnamorelin is currently under development for the management of non-small lung cancer associated cachexia/anorexia.
More Information Supplier PageAnamorelin is currently under development for the management of non-small lung cancer associated cachexia/anorexia.
More Information Supplier PageLonafarnib (SCH 66336) is a selectively FPTase inhibitor for H-ras, K-ras-4B and N-ras with IC50 of 1.9 nM, 5.2 nM and 2.8 nM, respectively.
More Information Supplier PageLonafarnib (SCH 66336) is a selectively FPTase inhibitor for H-ras, K-ras-4B and N-ras with IC50 of 1.9 nM, 5.2 nM and 2.8 nM, respectively.
More Information Supplier PageLonafarnib (SCH 66336) is a selectively FPTase inhibitor for H-ras, K-ras-4B and N-ras with IC50 of 1.9 nM, 5.2 nM and 2.8 nM, respectively.
More Information Supplier PageLonafarnib (SCH 66336) is a selectively FPTase inhibitor for H-ras, K-ras-4B and N-ras with IC50 of 1.9 nM, 5.2 nM and 2.8 nM, respectively.
More Information Supplier Page